Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension [Phase 1]
Phase 1 trial of dimethyl fumarate in systemic sclerosis-associated pulmonary arterial hypertension has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients [Phase 2]
Phase 2 trial evaluating IV iron replacement for iron deficiency in idiopathic pulmonary arterial hypertension completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002) [Phase 1]
A Phase 1 study evaluating single doses of Frespaciguat (MK-5475) on pulmonary vascular resistance in patients with pulmonary arterial hyper…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension [Phase 3]
This clinical trial update reports the completion of a Phase 3 study evaluating the long-term safety and tolerability of ACT 064992 in patie…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Oral CXA-10 in Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial update for oral CXA-10 in pulmonary arterial hypertension; study terminated with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension [Phase 2]
Phase 2 clinical trial update reporting long-term safety and efficacy of ralinepag in pulmonary arterial hypertension.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT [Phase 2]
A Phase 2 clinical trial (LARIAT) evaluating Bardoxolone Methyl in patients with pulmonary hypertension has completed and results have been …
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: A Mobile Health Intervention in Pulmonary Arterial Hypertension [NA]
Clinical trial update for a mobile health intervention in pulmonary arterial hypertension; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants [Phase 3]
Phase 3 study assessing pharmacokinetic effects of QTI571 on sildenafil and bosentan in pulmonary arterial hypertension; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Riociguat in Children With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Phase 3 trial update for riociguat in children with pulmonary arterial hypertension, with results posted in May 2021 and the study currently…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension [Phase 3]
Open-label extension trial of UT-15C sustained-release in pulmonary arterial hypertension completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Angiogenic Imaging in Pulmonary Arterial Hypertension [Phase 1, Phase 2]
Phase 1 and Phase 2 clinical trial update on angiogenic imaging in patients with pulmonary arterial hypertension, completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
Clinical trial update reporting results for patient global impression questions addressing activity-induced symptoms in participants with pu…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension. [Phase 4]
Phase 4 trial evaluating the effect of selexipag on daily life physical activity in patients with pulmonary arterial hypertension; results w…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 study evaluating 20, 40, and 80 mg of sildenafil taken three times daily for pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 study assessing long-term safety of sildenafil citrate in patients with pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy [Phase 4]
Phase 4 trial comparing riociguat to PDE-5 inhibitor therapy in pulmonary arterial hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension [Phase 3]
Phase 3 long-term extension study of BAY63-2521 in patients with pulmonary arterial hypertension has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 compassionate use trial update for beraprost sodium 314d modified release in pulmonary arterial hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 dose-response study evaluating safety and efficacy of beraprost sodium modified release in pulmonary arterial hypertension has compl…
-
CLINICAL_TRIALS trial_result · 2020-09-24Clinical Trial Update: REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension [Phase 4]
A Phase 4 trial investigating right ventricular remodeling in pulmonary arterial hypertension has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension [Phase 3]
Phase 3 trial evaluating initial triple oral therapy versus initial dual therapy in newly diagnosed pulmonary arterial hypertension; results…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial update on treprostinil for patients with pulmonary arterial hypertension associated with interstitial lung disease, including …
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension [Phase 3]
A Phase 3 trial of BPS-314d-MR-PAH-303 in pulmonary arterial hypertension was terminated; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension [Phase 2]
Phase 2 trial reporting safety and efficacy data for APD811 in pulmonary arterial hypertension has completed with results posted.